Comparing Concomitant Use of ACell MicroMatrix® and ACell Cytal™ to Standard of Care in Stage 3 or 4 Pressure Injuries
Clinical trial NCT03283787 · COMPLETED
Trial details
- NCT number
- NCT03283787
- Sponsor
- Integra LifeSciences Corporation
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2017-04-01
- Primary completion
- 2019-09-25
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.